NCT04985656View on ClinicalTrials.gov

A Study of Pevonedistat Combined With Decitabine and Cedazuridine in Adults With Higher-risk Myelodysplastic Syndromes

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 1, 2021

Primary Completion Date

January 8, 2024

Study Completion Date

November 8, 2024

Conditions
Myelodysplastic Syndromes (MDS)
Interventions
DRUG

Pevonedistat

Pevonedistat IV infusion

DRUG

Decitabine

Decitabine tablets

DRUG

Cedazuridine

Cedazuridine tablets

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY